| Ms Janelle Lynn Hiester, MS, CCC-SLP/L | |
|
850 S 5th St, Allentown, PA 18103-3308 | |
| (610) 776-3578 | |
| Not Available |
| Full Name | Ms Janelle Lynn Hiester |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 850 S 5th St, Allentown, Pennsylvania |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326318783 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | SL009720 (Pennsylvania) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Janelle Lynn Hiester, MS, CCC-SLP/L 850 S 5th St, Allentown, PA 18103-3308 Ph: (610) 776-3578 | Ms Janelle Lynn Hiester, MS, CCC-SLP/L 850 S 5th St, Allentown, PA 18103-3308 Ph: (610) 776-3578 |
News Archive
A new study from Rhode Island Hospital has found that more than one in 10 catheter-related bloodstream infections due to Staph aureus in hospitalized adults are caused by infected peripheral venous catheters (PVC). The study points out the substantial medical burden that arises from complications from these infections due to the large number of such catheters used in hospitalized patients.
At a meeting of the American Society of Anesthesiologists in Atlanta, new standards were approved on preventing a rare but terrifying situation in which patients wake up during surgery and sometimes feel excruciating pain without being able to cry out.
​Student and faculty volunteers from the University of Houston College of Pharmacy (UHCOP) received national recognition this summer for their work to expand essential health care services for Houston's homeless population.
Pfizer Inc. announced today that the European Medicines Agency (EMA) has accepted Pfizer's regulatory submissions for review of two investigational compounds - crizotinib, an oral first-in-class anaplastic lymphoma kinase (ALK) inhibitor, for the treatment of patients with previously treated ALK-positive advanced non-small cell lung cancer (NSCLC); and bosutinib for the treatment of adult patients with newly diagnosed Philadelphia chromosome positive (Ph+) chronic myeloid leukemia (CML) in the chronic phase.
Ipsen Biopharmaceuticals, Inc., the U.S. affiliate of Ipsen today announced that it has submitted a Supplemental New Drug Application to the U.S. Food and Drug Administration for Somatuline Depot 120mg injection for the treatment of gastroenteropancreatic neuroendocrine tumors (GEP-NETs).
› Verified 1 days ago
Adrienne Westheim, M.S, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 930 Springhouse Rd, Allentown, PA 18104 Phone: 610-390-5014 Fax: 610-398-7134 | |
Bailey Mckeon, M.A, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1925 W Turner St, Allentown, PA 18104 Phone: 610-794-5264 | |
Sarah Wanuga, MS, CCC-SLP/L Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 850 S 5th St, Allentown, PA 18103 Phone: 610-776-3578 | |
Megan Pellek, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 350 S Cedarbrook Rd, Allentown, PA 18104 Phone: 610-395-3727 Fax: 610-395-7919 | |
Cailee Carmella, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4136 W Tilghman St Apt 5, Allentown, PA 18104 Phone: 484-822-6040 | |
Ellen Susan Krajcir, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 850 S 5th St, Allentown, PA 18103 Phone: 610-776-3578 | |
Tiffany Ferreira, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1200 S Cedar Crest Blvd, Allentown, PA 18103 Phone: 888-402-5846 |